Biophytis SA
CIK 0001768946 · Pharmaceutical Preparations
Revenue (TTM)
—
FY Dec 2023
Net Income (TTM)
−€17.03M
+29.7% YoY
FY Dec 2023
EPS Diluted (TTM)
−€0.03
+78.6% YoY
FY Dec 2023
Gross Margin
—
FY Dec 2023
Operating Margin
—
FY Dec 2023
Net Margin
—
FY Dec 2023
Free Cash Flow (TTM)
—
FY Dec 2023
Cash
€5.57M
FY Dec 2023
Total Debt
—
FY Dec 2023
Shares Outstanding
1.04B sh
FY Dec 2023
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.